Pancreatic cancers developed in KRAS-induced carcinomas and NUPR1-deficient mice exhibited a higher expression of stemness markers (ALDH1, SOX2, Oct-4) compared to tumors originated in NUPR1-WT mice [100]. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.